June 20, 2023 8:07am

A “holiday” shortened week as June progresses to end Q2

Pre-open Indication: 2 Positive

My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today, not tomorrow or yesterday.

Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!  Never leave an investor uninformed! 

8:00 a.m. edition

Remember that overnight and pre-open actions in futures don't necessarily translate into actual trading in the coming day’s session. My interpretation of the morning’s numbers is written to be informative; it’s built on what will happen behind the headlines today, not tomorrow or yesterday

 

Dow futures are DOWN -0.31% or (-108 points), S&P futures are DOWN -0.28% or (-12 points) and NASDAQ futures are DOWN -0.24% or (-37 points) early in the pre-open – so far

Stock futures are falling on Tuesday

European markets fell

Asia Pacific markets were mixed

 

Henry’omics:

We need to more than consider the economic environment - rising rates and inflation to comprehend the micro re “our” universe of cell and gene therapy companies …

Monday was a market closed holiday, Friday, indexes were subdued i.e., slower on the uptake as The Dow closed DOWN -108.94 points (-0.32%), the S&P closed DOWN -16.25 points (-0.37%) while the Nasdaq closed DOWN -93.25 points (-0.68%)

Monday was a “holiday” and markets were closed due to the Juneteenth holiday.

Investors were “seemingly receptive” toward the central bank’s decision to skip a June rate hike last week. <CNBC>

 

Friday (6/16) … RegMed Investors’ (RMi) closing bell: “an intense week. It did come to an end, down like I thought it would.” … https://www.regmedinvestors.com/articles/13008

 

Ebb and flow:

Q2/23 – June: 1 market holiday, 4 negative and 8 positive closes

·         May – 10 negative and 12 positive closes

·         April ended - 1 holiday, 8 positive close and 11 negative closes

Q1/23 –

·         March – ended with 10 positive and 13 negative closes

·         February – 1 holiday, 2 vacation, 7 negative and 8 positive closes

·         January – 2 holidays, 11 positive and 9 negative closes

 

Companies in my headlights – It’s your decision; I provide ideas and context: INDICATIONS

Positive Indication:

Friday’s closing price, aftermarket dollar ($) and cent ($0.00) value and percentage (%)

UniQure NV (QURE) closed Friday at +$0.44 with a positive +$0.55 or +2.83% preopen indication. <see news below title)

Precigen (PGEN) closed Friday -$0.05 with a positive +$0.08 or +6.56% pre-open indication as the FDA has granted Breakthrough Therapy Designation for the first-in-class investigational PRGN-2012 AdenoVerse immunotherapy for the treatment of recurrent respiratory papillomatosis (RRP).

 

The BOTTOM LINE:

I follow the dictum, quoting Churchill that “short words are best, and the old words when short are best of all, as I try to keep it simple and short!

Had a “big” fight raking-out the loom and mulch, the rake won as I threw out my back – thank you Dr. Waller, chiropractor (Bolton, Mass) who more than popped me back into shape – some what ...but, being flat on my back for three (3) days taught me a lesson.

Thus, less on this sector as I haven’t seen much!

I also hate to be so negative or contrarian but, this is a NO spin zone and truth is its product; I can always be WRONG but, I am mostly EARLY!

At ANY time, this week, be ready to take partial profits and exit losers.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions securities referred to in this publication.